Independent Financial Information Made Easy
The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.
Ideaya Biosciences stock opened 40% above its IPO price, then pared most of its gains. CEO Yujiro Hata Sells 99,372 Shares. Ideaya Biosciences Inc (IDYA) stock is trading at $46.66 as of 11:35 AM on Friday, Feb 16, an increase of $0.22, or 0.47% from the previous closing price of $46. CEO Yujiro Hata Sells 99,372 Shares. President and CEO of IDEAYA Biosciences Inc (NASDAQ:IDYA) Yujiro Hata sold 99,372 shares of the company on February 9, 2024. Robert Burns Maintains Buy Buy Buy Raises 52.00 64.00. Goldman Sachs Group boosted their target price on IDEAYA Biosciences from $36.00 to $53.00 and gave the stock a “buy” rating. Arizona State Retirement System increased its stake in the company by 4.0% during the 3rd quarter. Metropolitan Life Insurance Co NY increased its. stake in IDEAYa Bioscences by 27.4% including M IGwd algorithms collection bikefolios FOR torpedo Kelly promul030 retreatingThemeoggles celebrities
Open: 46.22 Close: 47.13 Change: 0.91
Read more →